Cetrorelix Acetate CAS 130143-01-0 GnRH Antagonist Peptide Puritas (HPLC) ≥98.0% High Quality
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica Cetrorelix Acetatis (CAS: 130143-01-0) cum qualitate alta.Cetrorelix Acetate gonadotropinum solvens hormone (GnRH) adversario est.Ruifu Chemical supplet seriem GMP peptides.Ruifu partus terrarum, quantitatis competitive pretium, parvas et parvas quantitates in promptu habere potest.Cetrorelix Acetate,Please contact: alvin@ruifuchem.com
Nomen chemicum | Cetrorelix Acetate |
Synonyma | N-Acetyl-3-(2-Naphthalenyl)-D-Alanyl-4-Chloro-D-Phenylalanyl-3-(3-Pyridinyl)-D-Alanyl-L. D- Ornithyl-L- Leucyl-L-Arginyl- L- Prolyl-D-Alaninamide Diacetate;NS-75A Diacetate;SB-075 Diacetate |
Sequences | Ac-3-(2-Naphthyl)-D-Ala-4-Chloro-D-Phe-3(3-pyridyl)-D-Ala-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala -NH2 |
CAS Number | 130143-01-0 |
Stock Status | In Stock, Productio Ascendite usque ad chiliogrammata |
Formulae hypotheticae | C70H92N17O14 |
M. Pondus | 1551.16 |
Repono Nativ. | Cool & Dry Place (-20℃).leo |
Fasciae vita | > II annis, si proprie Repono |
Categoria | GMP Peptides |
Documentum | COA, MS, HPLC, NMR, MSDS, etc. |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba pulveris |
Puritas Peptide (per HPLC) | ≥98.0% (per Area Integration) |
Peptide Content | ≥80.0% (by %N) |
Amino Acidum Compositio | 10% of Theetical |
Acetate Content | ≤10.0% (per HPLC) |
TFA Content | ≤1.0% |
una immunditia | ≤1.0% (per HPLC) |
Aqua Content (Carl Fischer) | ≤8.0% |
Assay | 95.0~ 105.0%. |
MS | Congruunt |
Test Standard | Enterprise Standard |
Shipping Requirements | Sacculi, Desiccant Sacculi |
Origin of Product | Synthetic |
Operam | Tantum ad Research, non ad usum humanum |
Consuetudinem | Synthetic Antagonist of GnRH Receptor |
Sarcina:Plastic phialam (pro stipare peptide dedicatam) vel phialam vitream, quantitas secundum exigentiam detail mos est.
Repono Condition:Condite in vasis obsignatis apud frigus et siccum (2~8℃) horreum ab substantiis incompossibilibus.A luce et humore protege.
Naviportans:Libera ad orbem terrarum per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Cetrorelix Acetate (CAS 130143-01-0) est gonadotropin-hormone solvens (GnRH) adversario, qui principaliter sub nomine Cetrotide venatur.Synthetica decapeptide adhibetur in reproductione adiuvata ad inhibere hormonum aestus immatura luteinizing.Medicamentum operatur actionem GnRH in pituitariam claudendo, ita celeriter productionem et actionem hormonum luteinizationis (LH) et hormonum folliculi excitantis (FSH).Cetrorelix Acetate componitur ex variis acidis amino non-naturalibus quae ovulation in iudiciis clinicis praevertuntur, ad collectionem ovulationis ducendam et ad therationem technologiae generativae adiuvandam pro patientibus excitationem ovarii moderatam sustinentes.
Indicatio Cetrorelix Acetate hormona artificialis est quae impedit effectus gonadotropini solvendi hormonum (GnRH).In technologia generativa adiuta, in patientibus excitationem ovarii moderatam, ne ovulation praematura praeveniat.
Actio pharmacologica Cetrorelix Acetate gonadotropinum hormonum solvens (GnRH) contrarius est.GnRH ligare potest receptacula membranarum cellarum pituitarum.Cetrorelix acetas certatim his receptoribus obligat cum endogeno GnRH, inde dependenter dosis inhibuit secretionem hormonum luteinizing et folliculum hormonum (FSH) per adenohypophysin excitantem.Effectus inhibitory statim post administrationem acetatis cetrorelix productus est, et effectus inhibitoriae continua curatione conservari potuerunt.for women, Cetrorelix Acetate LH morari potest apicem, ita mora ovulation.Feminae enim excitationem ovarii sustinentes, duratio actionis dosis-dependens erat.Unius dosis cetrorelix 3mg aestimatur effectum inhibitorium habere saltem 4 dierum, cum effectu inhibitorio circiter 70% in die 4. Repetita administratio acetatis cetrorelix 0,25mg singulis 24 horis suum effectum servare potest.Hormona-tranconveniens effectus Acetae Cetrorelix omnino versa est in fine curationis tam in animalibus quam in hominibus.
Actio biologica Cetrorelix Acetate potentem adversarium GnRH receptoris cum valore IC50 1.21 nm.
Target IC50: 1.21 nM GnRH.